Back
to home » Treatment News » AIDSmeds Special Reports
 October 23, 2007
|
Worth the Wait: Isentress Arrives
The first HIV-fighting integrase inhibitor hits pharmacy shelves this week. While the development of Isentress and its chemical cousins has been a long and arduous process, the timing of its approval is impeccable.
|
|
|
October 08, 2007
|
Lessons From a Vaccine Failure
The premature closing of a large clinical trial testing Merck's preventive HIV vaccine is hardly good news. But there's always something to be learned from failure.
|
|
|
|
|
